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Abstract
Background:  Nephropathic cystinosis is an autosomal recessive disease resulting from
intracellular accumulation of cystine leading to multiple organ failure.
Case report: We describe the clinical course of a patient managed from the age of six until his
death at the age of 33 years. He underwent multiple surgery, including two renal transplants,
developed transplant renal artery stenosis that was managed medically, and progressive heart
failure at the age of 33 years. His death from a ruptured pseudoaneurysm associated with a
restrictive cardiomyopathy is noteworthy. A limited cardiac autopsy revealed the presence of
cystine crystals in interstitial cardiac histiocytes and one myocardial cell, along with 1000-fold
higher tissue cystine content of the left ventricular myocardium compared to patients without
cystinosis, suggesting the possibility of direct cystine mediated metabolic injury.
Background
Nephropathic cystinosis is an autosomal recessive disor-
der characterized clinically by generalized proximal renal
tubular dysfunction, progressive renal damage after intra-
cellular accumulation of cystine [1,2]. The result is the
buildup of cystine in various organs and eventual multi-
ple organ failure. In the kidney, it leads to progressive re-
nal damage, resulting in end-stage renal disease (ESRD)
by 10 years of age on average [1,2]. The drug cysteamine
reduces intracellular concentrations of cystine and can re-
tard progression of renal damage if started early [1,2]. Re-
nal transplantation is a viable option and the graft
survival is excellent [3]. The gene for cystinosis which has
been cloned and identified as CTNS, maps to chromo-
some 17p13 [4]. In the European population, mutations
of  CTNS include a 65-kb deletion-involving marker
D17S829 and 11 other small mutations [4]. Other CTNS
mutations have been confirmed in American-based popu-
lations of cystinosis patients [5]. We describe the clinical
course of a nephropathic form of cystinosis diagnosed at
the age of five years and managed at Albert Einstein Col-
lege of Medicine from the age of six for the next 27 years.
His survival despite multiple complications, and his death
at 33 years of age due to a ruptured pseudoaneurysm as-
sociated with cardiomyopathy, is noteworthy.
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Case report
A one-year old white male child was found to have rickets
and was treated with oral vitamin D. He was noted to be
growth retarded, and to have albuminuria and aminoaci-
duria. He received 50,000 units of vitamin D daily, off and
on until the age of five. He was then seen at another insti-
tution where he underwent renal and bone marrow biop-
sies. The biopsies revealed cystine deposits;
opthalmological examination confirmed the diagnosis of
cystinosis. He was then referred to Albert Einstein College
of Medicine for further management. At the age of six
years, the patient had growth retardation, renal osteodys-
trophy, albuminuria, glucosuria and chronic renal insuffi-
ciency. A creatinine clearance measured later revealed
20% GFR. He was managed conservatively until he
reached ESRD, at the age of 11 years. Four months after in-
itiation of hemodialysis, he developed a persistent fever
with fatigue and orthopnea. Physical exam revealed a
blood pressure (BP) of 137/101 mm of Hg, an enlarged
liver, distended neck veins and pericardial rub. The EKG
revealed right atrial and left ventricular enlargement. A
clinical diagnosis of uremic pericarditis was made and ag-
gressive dialysis was initiated. The patient responded to
aggressive dialysis and hydralazine, guanethidione and
methyldopa, for BP control. Subsequently, he developed
other complications of cystinosis, namely hypothy-
roidism, hypersplenism and corneal deposition of cystine
with diffuse pigmented mottling of the entire eye and fun-
dus. A splenectomy was performed at the age of 11 years.
The spleen weighed 310 grams and was laden with cystine
deposits. At that time his medications included antihyper-
tensives, digoxin, bicarbonate, testosterone, L-thyroxine,
calcium and vitamin D.
At the age of 12 years, he received a cadaveric renal trans-
plant. He had mild reversible rejection in the first year but
maintained normal renal function on azathioprine and
prednisone. Four years later, he developed chronic rejec-
tion eventually needing dialysis two years later. An arter-
io-venous (AV) fistula was created on his right arm. His BP
remained persistently above 170/110 mm of Hg. Ne-
phrectomies of transplant and native kidneys along with
propanolol, minoxidil, hydralazine, and methyldopa
were needed to control his BP. At the age of 18 years he re-
ceived his second cadaveric renal transplant. Four months
later, due to persistent uncontrolled hypertension and el-
evated serum renin (>500 ng/dl/hr), he underwent a
transplant arteriogram. It revealed a significant of narrow-
ing of the transplant renal artery, one inch distal to the
anastomosis, and a slight post-stenotic dilatation. It was
decided to medically control hypertension with hydro-
chlorthiazide, minoxidil, and propanolol. At that time he
had a complete slip of both femoral epiphyses and his
bones showed signs of chronic renal osteodystrophy.
With rehabilitation using crutches and surgical correction
of his genu valgum he was able to ambulate.
For the ensuing 12 years he had a relatively unremarkable
course. He had stable renal function with a serum creati-
nine of 0.8 mg/dl and satisfactory BP control. Annual
echocardiograms revealed mild atrial enlargements, mild
pulmonic insufficiency and left ventricular hypertrophy
with normal systolic function with an ejection fraction
(EF) of 68%. His medications included hydrochlorthi-
azide, propranolol, minoxidil, L-thyroxine, azathioprine
and prednisone. His vision refracted to 20/20 in each eye
with a correction for mixed astigmatism. He used artificial
tears when needed. At the age of 30 he began reporting in-
creasing fatigue, exercise intolerance, and generalized ede-
ma. Physical examination confirmed heart failure and
furosemide and digitalis were needed for a short period to
stabilize his condition. Repair of a large AV fistula did not
alter his symptoms. He was readmitted with crampy, per-
sistent abdominal pain. An ultrasound revealed a pseu-
doaneurysm at the site of the transplant renal artery
anastomosis. Gallstones were also noted. After extensive
consultations, he was considered a high operative risk and
a decision was made to manage him conservatively.
At the age of 33 years he again presented with extreme fa-
tigue and edema. A chest x-ray demonstrated cardiomega-
ly and bilateral pleural effusions. An echocardiogram
showed biventricular hypertrophy with normal left ven-
tricular EF (72%), bilateral atrial enlargement and a dilat-
ed aortic root. He was treated with diuretic therapy and
digitalis but with limited response. He was subsequently
admitted to the hospital in a dehydrated state following a
short viral illness. He developed sudden hypotension and
worsening of abdominal pain. A CT scan of the abdomen
revealed a ruptured abdominal aneurysm. Surgical inter-
vention was attempted, but the patient died on the oper-
ating table due to massive blood loss.
Post-mortem examination
A restricted post-mortem examination, limited by the
family to cardiac biopsy, was performed within 10 hours
of death. At the biopsy site 4 cm above the apex, the ante-
rior left ventricular wall measured 2.5 cm in thickness. The
left ventricular myocardium showed prominent myocyte
hypertrophy with interstitial and perivascular fibrosis.
Electron microscopy revealed rectangular intralysosomal
crystals characteristic of cystine within interstitial histio-
cytes lying adjacent to myocytes (fig. 1). A single myocyte
containing crystalline inclusions suggestive of cystine was
identified (fig 2). Tissue cystine content was measured us-
ing a cystine binding protein assay [6]. The cystine content
of the left ventricular myocardium was 18.5 nmol half cys-
tine per mg of wet tissue as compared to myocardium
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whom it was 0.09–0.081 nmol half cystine per mg of wet
tissue. Thus, the tissue cystine level was 1000-fold higher
than normal.
Discussion
Cystinosis is an autosomal recessive disorder character-
ized by excessive storage of cystine in several organs, in-
cluding kidney, spleen, liver, lymph node, cornea and
thyroid gland [1,2]. Individuals typically present in the
first year of the life with symptoms of severe fluid and
electrolyte disturbance, a renal Fanconi syndrome, growth
failure, and photophobia. Without specific treatment,
they progress to end-stage renal failure (ESRD) by end of
the first decade. A rare 'late-onset' form of cystinosis
presents in older children with renal impairment but not
necessarily a Fanconi syndrome. Adults with 'benign'
cystinosis have asymptotic corneal cystine deposition but
do not have progressive renal damage [1,2,7,8]. The diag-
nosis of nephropathic cystinosis can be confirmed by slit
lamp examination of the cornea which reveals needle
shaped, tinsel-like refractive opacities. The levels of cys-
tine can be measured in bone-marrow cells, leukocytes,
and cells of the rectal mucosa [1,2,7,8]. Renal involve-
ment is characterized by cystine depositions in the inter-
stitium as well as glomerular and tubular epithelium.
With disease progression there is tubular atrophy, intersti-
tial fibrosis, glomerulosclerosis and eventual obsoles-
cence of the glomeruli. Though hypertension is relatively
uncommon in these patients. When patients reach ESRD,
dialysis or transplantation are reasonable options. Graft
survival in these patients is similar to that observed in
ESRD of other etiologies [3]. However, cystine continues
to accumulate in other organs, leading to multisystem dis-
ease. Oral cysteamine can retard progression of renal
damage if started early in the course of the disease and if
given for prolonged periods [2,9]. Oral cysteamine must
be continued even after transplant to prevent ongoing ac-
cumulation of cystine [2,9]. By the time oral cysteamine
became routinely available the patient had significant
progression and therefore was not treated.
Development of aneurysm or pseudoanerysm of a major
vessel in patients with nephropathic cystinosis is quite
rare. In fact, there is only one other report of a dissecting
aortic aneurysm in a 7-year old boy in whom cystine crys-
tals were absent from the aortic wall [10]. As the his-
topathological examination of pseudoanerysm was not
carried out the exact etiology remains unknown. Cardio-
myopathy associated with cystinosis was also not reported
prior to the patient described here. In the literature there
are two other reports of myocardial cystine deposition in
patients with cystinosis [11,12]. The first report was of a
Figure 1
Electron microscopy picture of the myocardium with the
interstitium showing cystine rectangular crystal (× 15,000).
Figure 2
Myocardium with the interstitial histiocytes with rectangular
cystine crystal.BMC Nephrology 2002, 3 http://www.biomedcentral.com/1471-2369/3/8
Page 4 of 4
(page number not for citation purposes)
22-year old male with cystinosis and myopathy [11] who
had a myocardial cystine level of 8.7 nmol half cystine per
mg of wet tissue (as compared to 18.5 nmol half cystine
per mg of wet tissue patient described here). The other pa-
tient was a 43 year old woman with a late-onset cystinosis
in whom cystine crystals were observed in the myocar-
dium at autopsy [12]. Neither of the two patients had car-
diomyopathies. The myocardial cystine load in those two
patients may not have been as heavy as in patient de-
scribed here. It is possible that if the patient described by
us had received cysteamine from a very early age, it could
have reduced the cystine content in the myocardium. In
another series of 13 post-renal-transplant cystinosis pa-
tients with distal vacuolar myopathy the cardiac ejection
fractions and the wall motions were within normal limits
and none of the patients had evidence of cardiac dysfunc-
tion [13]. The skeletal muscle cystine levels measured in
those patients were similar to myocardial cystine level in
the patient described here [13].
The pericarditis at the age of 11 years was attributed to in-
sufficient dialysis and the response to more aggressive di-
alysis was considered as a satisfactory confirmation of the
diagnosis. As the patient was ambulatory and had no fur-
ther symptoms of heart failure for years after that episode,
its role in the development of a restrictive cardiomyopa-
thy twenty years later is unlikely. Annual echocardiograms
and periodic cardiac evaluation allowed a fair evaluation
of the cardiac status. The severe concentric left ventricular
hypertrophy was out of proportion to the degree of hyper-
tension of a long standing duration. Evidence of diastolic
dysfunction manifested by pulmonary congestion and bi-
lateral pleural effusions, with a normal left ventricular
ejection fraction, point towards a restrictive cardiomyop-
athy. This could have been the consequence of long stand-
ing hypertension, uremia, a large AV fistula, and altered
calcium-phosphorous metabolism due to renal osteodys-
trophy. However, the presence of cystine crystals in inter-
stitial cardiac histiocytes and one myocardial cell, along
with 1000-fold higher tissue cystine content of the left
ventricular myocardium point towards the possibility of
direct cystine mediated metabolic injury. Notably, his
symptoms did not resolve after aggressive medical control
of BP, surgical closure of the fistula and digitalis/diuretic
therapy. The stress of profuse internal bleeding from the
rupture of the pseudoaneurysm in conjunction with a
weakened cardiac status, resulted in his death. As the pa-
tient described here never received cysteamine, the role of
this drug in prevention of cardiomyopathy associated
with cystinosis remains to be evaluated.
In summary, we describe the clinical course of a nephro-
pathic cystinosis patient managed from the age of six until
his death at the age of 33 years. His long-term survival, as-
sociated cardiomyopathy and death due to ruptured pseu-
doaneurysm are noteworthy.
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